Connor, Clark & Lunn Investment Management Ltd. - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 90 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$590,000
-35.2%
23,814
-46.3%
0.00%
-33.3%
Q2 2017$911,000
+327.7%
44,325
+352.3%
0.01%
+500.0%
Q1 2017$213,000–9,800–0.00%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders